They selected the ArcAβ mice carrying mutant human amyloid precursor protein (APP) as their AD model, and found that the AD mice had decreased endothelial and astrocytic GLUT1expression accompanied with a reduced baseline brain glucose level. The gene discussed is APP; the disease is Alzheimer disease.